On 31 October 2021, NICE published an updated version of the ME/CFS clinical guideline following their consultation. The RCPCH consulted on the guideline in November 2020 and continued to meet with the National Institute for Health and Care Excellence (NICE) as they worked with patient groups and representative organisations to finalise the guideline.
The RCPCH raised a number of issues in the consultation on the draft guideline (RCPCH’s response is on pages 742-775), including safeguarding of children and young people (CYP), practicalities of assessment and recommended therapies.
We hope this briefing, which contains our view on some of the new recommendations, will support paediatricians in taking the new guidance forward.
Click to read our briefing